Opthea Limited filed Form 6-K on February 18, 2025, detailing completion of COAST trial milestones and regulatory compliance. Insights by CEO Frederic Guerard.
Explore Opthea Limited's latest 6-K filing detailing financial highlights, cash position, and corporate updates as of January 2025. Stay informed on key developments!
Discover Opthea Limited's latest 6-K report filed on Jan 8, 2025, detailing investor days in NY & Australia. Get insights on company updates and CEO Frederic Guerard's signature.
Discover Opthea Limited's significant developments in its January 2025 Form 6-K filing, including a vital press release on Diabetic Macular Edema. Stay informed!
Explore Opthea Limited's latest Form 6-K filing, detailing compliance, CEO insights, and their upcoming presence at the J.P. Morgan Healthcare Conference.